Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

被引：0

作者：

Zhenhao Fang

Lei Peng

Carolina Lucas

Qianqian Lin

Liqun Zhou

Luojia Yang

Yanzhi Feng

Ping Ren

Paul A. Renauer

Valter S. Monteiro

Anne M. Hahn

Jonathan J. Park

Xiaoyu Zhou

Nathan D. Grubaugh

Craig B. Wilen

Sidi Chen

机构：

[1] Yale University School of Medicine,Department of Genetics

[2] Yale University,System Biology Institute

[3] Yale University,Center for Cancer Systems Biology

[4] Yale University,Department of Immunobiology

[5] Yale University,Immunobiology Program

[6] Yale University,Molecular Cell Biology, Genetics, and Development Program

[7] Yale School of Public Health,Department of Epidemiology of Microbial Diseases

[8] Yale University,Department of Ecology and Evolutionary Biology

[9] Yale University,MD

[10] Yale University,PhD Program

[11] Yale University School of Medicine,Department of Laboratory Medicine

[12] Yale University School of Medicine,Comprehensive Cancer Center

[13] Yale University School of Medicine,Stem Cell Center

[14] Yale School of Public Health,Center for Biomedical Data Science

[15] Yale Center for Genome Analysis,undefined

[16] Yale School of Medicine,undefined

来源：

Cell Discovery | / 8卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 12 条

[1]

Elbe S(2017)Data, disease and diplomacy: GISAID’s innovative contribution to global health Glob. Chall. 1 33-46

[2]

Buckland-Merrett G(2021)Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization Nature 602 654-656

[3]

Cele S(2022)Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 Nat. Commun. 13 3250-1505

[4]

Fang Z(2022)Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2 Cell Rep. Med 3 100634-556

[5]

Peng L(2020)Structure-based design of prefusion-stabilized SARS-CoV-2 spikes Science 369 1501-531

[6]

Hsieh CL(2022)Antibody evasion properties of SARS-CoV-2 Omicron sublineages Nature 604 553-416

[7]

Iketani S(2021)Genetic variants of SARS-CoV-2-what do they mean? JAMA 325 529-2615

[8]

Lauring AS(2021)Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine N. Engl. J. Med. 384 403-529

[9]

Hodcroft EB(2020)Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine N. Engl. J. Med. 383 2603-undefined

[10]

Baden LR(2021)Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity Nature 600 523-undefined

← 1 2 →